Literature DB >> 17564629

Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome.

J Tayama1, Y Sagami, Y Shimada, M Hongo, S Fukudo.   

Abstract

Patients with irritable bowel syndrome (IBS) may have a higher tone of corticotropin-releasing hormone (CRH) in the brain. We tested our hypothesis that peripheral administration of CRH antagonist, alpha-helical CRH(9-41) (alphahCRH), improves decreased alpha power spectra and increased beta power spectra of electroencephalogram (EEG) in IBS patients. A barostat bag was inserted to the descending colon of 10 normal controls and 10 IBS patients. The EEG power spectra and topography were measured during baseline period and colonic distention period with the administration of saline followed by the administration of 10 microg kg(-1) of alphahCRH. IBS patients showed a significantly lower alpha power percentage and a higher beta power percentage than normal controls during baseline. Colonic distention induced a decrease in the alpha power percentage and an increase in the beta power percentage in both groups without difference between groups. After the administration of alphahCRH, changes in the EEG power spectra in response to colonic distention were blunted and the differences in the EEG power spectra between IBS patients and controls vanished. Peripheral administration of alphahCRH almost normalized EEG activities in IBS patients. Our data strongly suggest that CRH plays an important role in IBS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564629     DOI: 10.1111/j.1365-2982.2007.00903.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  22 in total

Review 1.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

Review 2.  Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors:  M Larauche; C Kiank; Y Tache
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

3.  Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats.

Authors:  Jun-Ho La; Tae-Sik Sung; Hyun-Ju Kim; Tae-Wan Kim; Tong-Mook Kang; Il-Suk Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

Review 5.  Visceral analgesics: drugs with a great potential in functional disorders?

Authors:  Sylvie Bradesi; Jeremy Herman; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2008-09-26       Impact factor: 5.547

Review 6.  A role for corticotropin-releasing factor in functional gastrointestinal disorders.

Authors:  Yvette Taché; Cornelia Kiank; Andreas Stengel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

7.  Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner.

Authors:  G Zheng; S-P Wu; Y Hu; D E Smith; J W Wiley; S Hong
Journal:  Neurogastroenterol Motil       Date:  2013-02       Impact factor: 3.598

Review 8.  Review article: new receptor targets for medical therapy in irritable bowel syndrome.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2010-01       Impact factor: 8.171

9.  Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

Authors:  Muriel Larauche; Guillaume Gourcerol; Lixin Wang; Karina Pambukchian; Stefan Brunnhuber; David W Adelson; Jean Rivier; Mulugeta Million; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

10.  Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.

Authors:  Yong-Lan Huang; Jie-Ping Yu; Gao-Hua Wang; Zhen-Hua Chen; Qing Wang; Ling Xiao
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.